Legal and compliance professionals from pharmaceutical, medical device and biotechnology companies, and CROs, have chosen this program to connect, compare notes and expand their networks.
The 2022 program will stand apart and make up for lost time! Based on popular demand, the program has relocated the event to Boston, a key hub for the life sciences industry.
WilmerHale Partner Chris Cestaro will speak on a panel titled Former DOJ Officials Predict the Future of FCPA Investigations and Enforcement: Special Considerations for Pharmaceutical, Medical Device and Biotech Companies, and CROs on July 21 at 11 a.m.